Skip to main content
. 2021 Oct 14;12:738907. doi: 10.3389/fimmu.2021.738907

Figure 3.

Figure 3

Comparison of NRS score between two treatment groups. NRS score has decreased to varying degrees from weeks 0 to 2 in the dupilumab group (A) (*** p < 0.001 by Mann-Whitney U test), and the conventional group (B) (*** p < 0.001 by Mann-Whitney U test). (C) Patients in dupilumab group showed more privileges in relieving itch (p = 0.034 by two-way RM ANOVA).